What does MOTS-c stand for?

MOTS-c is Mitochondrial ORF of the 12S rRNA type-c: a 16-amino-acid peptide encoded in mitochondrial DNA, molecular weight about 2,174 daltons. The letters name where the sequence sits in the mitochondrial genome, not a brand and not a measured fat-loss result. Human evidence on this site is observational circulating levels, a mitochondrial DNA variant in 27,527 people, and an exercise-related rise in endogenous MOTS-c, plus a Phase 2a trial still recruiting (NCT07505745). Nobody on this site has yet published a trial of giving MOTS-c to a person as a finished drug.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.